PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer.

MLA

Zhou, Jing, et al. “PIM1 Kinase Promotes EMT-Associated Osimertinib Resistance via Regulating GSK3β Signaling Pathway in EGFR-Mutant Non-Small Cell Lung Cancer.” Cell Death & Disease, vol. 15, no. 9, Sept. 2024, p. 644. EBSCOhost, https://doi.org/10.1038/s41419-024-07039-0.

APA

Zhou, J., Wang, X., Li, Z., Wang, F., Cao, L., Chen, X., Huang, D., & Jiang, R. (2024). PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer. Cell Death & Disease, 15(9), 644. https://doi.org/10.1038/s41419-024-07039-0

Chicago

Zhou, Jing, Xinyue Wang, Zhaona Li, Fan Wang, Lianjing Cao, Xiuqiong Chen, Dingzhi Huang, and Richeng Jiang. 2024. “PIM1 Kinase Promotes EMT-Associated Osimertinib Resistance via Regulating GSK3β Signaling Pathway in EGFR-Mutant Non-Small Cell Lung Cancer.” Cell Death & Disease 15 (9): 644. doi:10.1038/s41419-024-07039-0.